Automate Your Wheel Strategy on GMED
With Tiblio's Option Bot, you can configure your own wheel strategy including GMED - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GMED
- Rev/Share 20.593
- Book/Share 32.7045
- PB 2.6739
- Debt/Equity 0.0271
- CurrentRatio 4.1299
- ROIC 0.073
- MktCap 11703645304.0
- FreeCF/Share 4.3093
- PFCF 20.1924
- PE 27.7555
- Debt/Assets 0.0234
- DivYield 0
- ROE 0.0999
- Rating A
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 3
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | GMED | Needham | Hold | Buy | -- | $112 | Jan. 30, 2026 |
| Initiation | GMED | TD Cowen | -- | Buy | -- | $110 | Jan. 27, 2026 |
| Upgrade | GMED | BofA Securities | Neutral | Buy | -- | $91 | Nov. 7, 2025 |
| Upgrade | GMED | Truist | Hold | Buy | -- | $93 | Nov. 7, 2025 |
| Resumed | GMED | Stifel | -- | Hold | -- | $64 | Oct. 28, 2025 |
| Downgrade | GMED | BTIG Research | Buy | Neutral | -- | -- | May 27, 2025 |
| Upgrade | GMED | BofA Securities | Underperform | Neutral | -- | $97 | Jan. 10, 2025 |
News
GMED vs. PEN: Which Stock Is the Better Value Option?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks is more attractive to value investors?
Read More
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Here's Why Globus Medical (GMED) is a Strong Growth Stock
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Positive
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Should You Still Hold GMED Stock in Your Portfolio?
Published: January 20, 2026 by: Zacks Investment Research
Sentiment: Positive
Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.
Read More
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term
Published: January 09, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Globus Medical (GMED) is a Strong Growth Stock
Published: December 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026
Published: December 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are some surging MedTech stocks - GMED, TMDX and HIMS - that may face slowing momentum in 2026.
Read More
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term
Published: December 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.
Read More
GMED or PEN: Which Is the Better Value Stock Right Now?
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
5 Momentum Stocks to Buy for December After a Mixed November
Published: December 01, 2025 by: Zacks Investment Research
Sentiment: Positive
December momentum picks gain traction as EXPE, ALL, DDS, KGC and GMED stand out after a mixed November.
Read More
Should You Buy Globus Medical (GMED) After Golden Cross?
Published: November 24, 2025 by: Zacks Investment Research
Sentiment: Positive
After reaching an important support level, Globus Medical, Inc. (GMED) could be a good stock pick from a technical perspective. GMED recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Read More
5 Top Stocks Driven by Strong Relative Price Strength Now
Published: November 17, 2025 by: Zacks Investment Research
Sentiment: Positive
PARR, AU, GMED, ALNT and SNDK emerge as top picks after posting gains, rising estimates and sustained relative price outperformance.
Read More
Globus Medical (GMED) is an Incredible Growth Stock: 3 Reasons Why
Published: November 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
Published: November 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy?
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Globus Medical: Straightening Its Back
Published: November 11, 2025 by: Seeking Alpha
Sentiment: Positive
Globus Medical has rebounded strongly, driven by accelerating earnings and successful integration of acquisitions like NuVasive and Nevro. The company delivered on robust Q3 results, with 7% organic growth and a significant hike in full-year adjusted earnings guidance to $3.80 per share. Despite a 35% share price surge, shares trades at a reasonable 21x earnings, supported by a strong balance sheet and ongoing synergy potential.
Read More
Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength.
Published: November 07, 2025 by: Barrons
Sentiment: Positive
Shares of the medical technology company are headed for their largest same-day percentage increase on record.
Read More
Today's Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical
Published: November 07, 2025 by: 24/7 Wall Street
Sentiment: Neutral
The image featured for this article is © Thinkstock
Read More
Globus Medical (GMED) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
Beyond analysts' top-and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Read More
Globus Medical (GMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Is Wall Street Underestimating Globus Medical Stock's Potential?
Published: October 22, 2025 by: Forbes
Sentiment: Positive
Here's why we believe Globus Medical (GMED) stock merits attention as a value stock. It's currently trading approximately 33% below its 1-year high and is also trading at a PS multiple that falls below the average over the past 3 years.
Read More
GMED vs. SONVY: Which Stock Is the Better Value Option?
Published: October 14, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Here's Why Globus Medical (GMED) is a Strong Value Stock
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Published: September 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?
Published: September 04, 2025 by: Zacks Investment Research
Sentiment: Negative
GMED rides strong musculoskeletal demand and new launches, but faces currency headwinds and fierce competition.
Read More
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Positive
GMED posts strong Q2 with earnings and revenues, boosted by the Nevro acquisition and expanded margins.
Read More
Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript
Published: August 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Globus Medical, Inc. (NYSE:GMED ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Brian J. Kearns - Senior Vice President of Business Development & Investor Relations David C.
Read More
Stay Ahead of the Game With Globus Medical (GMED) Q2 Earnings: Wall Street's Insights on Key Metrics
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Globus Medical (GMED), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Read More
About Globus Medical, Inc. (GMED)
- IPO Date 2012-08-03
- Website https://www.globusmedical.com
- Industry Medical - Devices
- CEO Keith W. Pfeil
- Employees 5300